Skip to main content
Robert Koch Jr., MD, Oncology, Saint Petersburg, FL, Edward White Hospital

RobertR.KochJr.MD

Oncology Saint Petersburg, FL

Physician

Dr. Koch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Koch's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1982
  • The MetroHealth System/Case Western Reserve University
    The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1976 - 1979
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1976

Certifications & Licensure

  • GU State Medical License
    GU State Medical License Active through 2025
  • FL State Medical License
    FL State Medical License 1982 - 2025
  • PA State Medical License
    PA State Medical License 2015 - 2024
  • NC State Medical License
    NC State Medical License 2000 - 2024
  • HI State Medical License
    HI State Medical License 2018 - 2022
  • MA State Medical License
    MA State Medical License 2017 - 2022
  • NM State Medical License
    NM State Medical License 2015 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Raymond L. Erikson, PhD: In Memoriam (1936–2020)
    Raymond L. Erikson, PhD: In Memoriam (1936–2020)June 5th, 2020
  • The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-like Phenotype
    The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-like PhenotypeMay 18th, 2020

Hospital Affiliations